Zenas BioPharma, Inc. (ZBIO)
NASDAQ: ZBIO · Real-Time Price · USD
17.29
-1.13 (-6.13%)
Sep 26, 2024, 4:00 PM EDT - Market closed
Zenas BioPharma Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2023 | FY 2022 |
| Sep '24 Sep 26, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
| Market Capitalization | 688 | - | - |
| Enterprise Value | 954 | - | - |
| Debt / Equity Ratio | 0.00 | 0.87 | 0.03 |
| Debt / FCF Ratio | -0.02 | -0.69 | -0.02 |
| Asset Turnover | - | 0.70 | - |
| Quick Ratio | 4.70 | 2.44 | 2.59 |
| Current Ratio | 4.82 | 2.57 | 2.64 |
| Return on Equity (ROE) | - | -102.89% | - |
| Return on Assets (ROA) | - | -23.77% | - |
| Return on Capital (ROIC) | - | -35.79% | - |
| Buyback Yield / Dilution | -3.89% | -2.62% | - |
| Total Shareholder Return | -3.89% | -2.62% | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.